Altimmune, Inc. Balance Sheet
ALT|10 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 10 fiscal years. All figures from audited SEC 10-K filings.
Altimmune, Inc. had $280M in total assets and $225M in shareholders' equity as of FY2025. Total debt was $34M against $44M in cash, resulting in a $9M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43.8M | $36.9M | $135.1M | $111.1M | $190.3M | $115.9M | $9.0M | $33.7M | $8.8M | $2.7M |
| Current Assets | $278.2M | $137.3M | $209.6M | $192.8M | $204.1M | $230.3M | $39.4M | $39.4M | $23.5M | $19.6M |
| PP&E (Net) | $312.0K | $413.0K | $651.0K | $1.1M | $1.4M | $1.1M | $1.1M | $1.3M | $603.1K | $788.7K |
| Goodwill | - | - | - | - | - | - | - | $0 | $18.8M | $2.3M |
| Total Assets | $279.9M | $139.3M | $210.6M | $206.9M | $218.9M | $245.1M | $54.1M | $54.8M | $63.0M | $22.8M |
| Current Liabilities | $15.0M | $10.5M | $12.1M | $17.1M | $18.3M | $12.0M | $3.9M | $4.5M | $3.8M | $4.6M |
| Total Debt | $34.3M | - | - | $4.6M | $1.5M | $1.8M | $1.9M | - | - | - |
| Shareholders' Equity | $224.9M | $194.1M | $185.3M | $199.1M | $225.9M | $45.5M | $48.3M | $39.4M | $32.2M | $3.2M |